“Everything was wonderful. I am now completely pain free and absolutely thrilled.”
Pioneering knee surgery
Neil Bradbury is working with some of the most technologically advanced companies in the world to develop new techniques and innovative ways of treating knee conditions. He is one of only a few orthopaedic surgeons in Europe to offer techniques which restore the natural biological knee.
Personalised knee implants allow noticeably more bone preservation than traditional knee replacement options. This preserves bone stock for potential future treatments.
An increase in sporting related injuries to the knee has resulted in rapid technological advances in the management of knee ligament and meniscal injuries, resulting in an earlier return to functionality and rehabilitation.
The knee specialists use innovative surgical techniques for the management of arthritis such as half or Uni-compartment knee replacement, patello-femoral (knee cap joint) replacement, osteotomy as well as performing total knee replacement.
- Custom-made Knees
- Articular Cartilage Replacement (grafting)
- Intra-Articular Protein Therapy
- Meniscal Scaffold
- Meniscal Allograft
Each implant is created specifically for you and exactly mirrors the surface contours of your knee, providing bone preservation. The implants also provides an anatomic fit with less bone cutting than traditional treatments.
Patients with unicompartmental disease are able to preserve their knee for future treatments and may also experience faster recovery time and reduced post-operative pain than with traditional total knee replacement. In addition, the unique instrumentation can improve alignment and provide a more natural feel to the knee, which can reduce implant wear and extend the life of the knee joint.
Use the link below to find out more about personalised knee implants.
Articular Cartilage Replacement (grafting)
The Chondrotissue Graft is the latest development in articular cartilage repair and or replacement surgery.
Damage to articular cartilage or damage to both the cartilage and the underlying bone does not repair itself spontaneously and results in joint pain and poor function. Thinning and roughening of the articular cartilage can progress to severe wear and eventually patches of bare bone rubbing on bare bone in the knee leading to arthritis.
Intra-Articular Protein Therapy
For osteoarthritis sufferers a single protein injection, harvested from a patient’s blood could replace the need for knee surgery.
nSTRIDE Autologous Protein Solution (APS) is a groundbreaking therapy designed to treat pain and slow the progression of cartilage degradation which can lead to destruction of the knee.
The new procedure involves the extraction of blood from the patient, separation in a centrifuge to obtain a concentrated suspension of platelets via plasmapheresis, followed by injection of part of the fluid into the knee.
During this process the blood undergoes a two-stage centrifugation process to separate the solid and liquid components. Blood is extracted from the patient’s vein, mixed with an anticoagulant and centrifuged at high speed for approximately 15 minutes, causing the blood to separate into three layers: a yellow blood plasma; a red blood cell concentration; and a ‘platelet-rich plasma’, a solution comprising platelet cells and some white blood cells.
The initial phase separates the plasma and platelets from the erythrocytes and leukocytes. The second stage uses a hard spin to concentrate the platelets further into platelet rich and poor plasma components. The platelet-rich plasma is extracted and centrifuged again for an additional two minutes until surgeons end up with a 3ml protein liquid. The final platelet rich plasma, known as autologous protein solution is then injected into the knee joint space.
The final product contains concentrated white blood cells, platelets, and plasma proteins in a small volume of plasma. The output is approximately a 2 to 3 cc anti-inflammatory solution.
The proposed nSTRIDE Autologous Protein Solution (APS) mechanism of action is a process of reducing osteoarthritis-related upregulated inflammatory cytokines by introducing antagonistic cytokines, which inhibit the inflammatory cytokine activity. nSTRIDE Autologous Protein Solution (APS) has been shown to reduce production of proteins associated with osteoarthritic inflammation and pain responses in vitro.
There is growing evidence to support its use for select indications in osteoarthritis (Kellgren-Lawrence Grade 2-3). Clinical studies have demonstrated the effectiveness of one single injection. Studies suggest one injection can last at least 12 months, with new evidence showing evidence upto 2 years post injection.
Read the latest reviews on nSTRIDE Autologous Protein Solution for the treatment of knee osteoarthritis.
There are two shock absorbers in the normal knee each called a meniscus. They are frequently injured or torn and tend not to heal because only the outer edge has a blood supply.
Some tears can be repaired by stitching the meniscus so that it can heal. The majority of meniscal tears are removed with an arthroscopy (keyhole surgery). If the amount removed is small most patients have no further problem but in patients where a large part of the meniscus is lost there is a risk of developing pain and early arthritis in the joint.
One solution for some patients is insertion of a meniscal scaffold. This is a procedure where a meniscus like scaffold is sewn into place with the aim of allowing the body’s tissue to grow into the scaffold and produce a new meniscus like shock absorber. It is a relatively new technique which has shown promising results.
There are two most frequently used scaffolds, the CMI implant and the Actifit implant. We offer both types of surgery.
Rehabilitation following this type of procedure is lengthy and patients require several weeks off work and months off sport.
For patients in which all of a meniscus is lost and a meniscal scaffold is not suitable, it is possible to insert a meniscal allograft.
An allograft is a human meniscus from a donor in much the same way that patients can have corneal or kidney transplants but without the need to prevent rejection with on-going drugs.
The patient’s knee is sized by X-ray and MRI scan and a matching meniscus is ordered for implantation. There are a number of sources for this type of implant.
This is complex surgery but can be performed using a keyhole technique. It is a relatively new technique and tends to be reserved for younger people in whom other treatments have failed.
Rehabilitation following this type of procedure is lengthy and patients require several weeks off work and sport.
Meet the team
Specialist Knee Surgeon & Orthopaedic Consultant
Neil is a nationally recognised Consultant Orthopaedic Surgeon specialising in knee surgery, providing a fully integrated medical service to patients with knee conditionsGet in touch »
Senior Physiotherapist & Clinical Specialist in Knees
Alex, a clinical specialist in knees, has a graduate Diploma in Physiotherapy and a Diploma in Sports & Exercise Medicine.Get in touch »
Senior Physiotherapist & Clinical Specialist in Knees
Genevieve is a clinical specialist in knees, having worked alongside Orthopaedic Consultant Neil Bradbury for many years.Get in touch »
Dr Julian Widdowson
Sports Medicine Doctor
Julian qualified from University College London and then obtained an MSc in Sports and Exercise Medicine from the University of Bath.Get in touch »